LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Determination of genotoxic impurity in atazanavir sulphate drug substance by LC–MS

Photo by schluditsch from unsplash

HighlightsA sensitive LC–MS method for GTI‐A, genotoxic impurity in atazanavir sulphate drug was developed.Method validation was done in respect of QL, DL, linearity and accuracy.Method: can be used in Quality… Click to show full abstract

HighlightsA sensitive LC–MS method for GTI‐A, genotoxic impurity in atazanavir sulphate drug was developed.Method validation was done in respect of QL, DL, linearity and accuracy.Method: can be used in Quality control laboratories of pharmaceutical industry if and when required. ABSTRACT A sensitive LC–MS method was developed for the determination of tert‐butyl 2‐[4‐(pyridine‐2‐yl) benzyl] hydrazine carboxylate (GTI‐A), a genotoxic impurity in Atazanavir sulphate drug substance. The method was validated as per International Council for Harmonization guidelines, for QL, DL, linearity and accuracy. The QL and DL values obtained were 1.1 ppm and 0.3 ppm respectively. The Correlation coefficient found for the linearity study was 0.999. The % recovery of the added impurity in the range of 96.4–100.4 ensured the accuracy of the method.

Keywords: atazanavir sulphate; sulphate drug; genotoxic impurity; method; impurity atazanavir; impurity

Journal Title: Journal of Pharmaceutical and Biomedical Analysis
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.